GlaucoCetin Peripheral Group for Glaucoma
This trial is testing whether a daily medical food can improve the vision of glaucoma patients.
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Is this testing opportunity still accepting participants?
"Affirmative. According to the records available on clinicaltrials.gov, recruitment for this medical investigation is still happening. It was first announced February 1st 2021 and most recently updated June 30th 2022 with the aim of enrolling a hundred patients across one site."
How can I become involved in this clinical experiment?
"This medical trial requires 100 individuals between the ages of 40 and 80 who have been diagnosed with open-angle glaucoma. Additionally, Group 1 must meet at least one Hodapp-Parrish-Anderson criterion for defect; Group 2 must demonstrate a paracentral point repeatedly depressed to p<1% on 24-2 testing. Moreover, both groups should possess bilateral open angle glaucoma that can be corroborated by visual field defects (MD between -4.00 to -10 dB). Lastly, all participants need to present with an acuity level of 20/40 or better in each eye."
Does the study include elderly candidates?
"The parameters for patient participation in this medical experiment stipulate that the youngest age eligible to enroll is 40, while the oldest participant must not exceed 80 years old."
What is the scope of this clinical trial's participant base?
"Affirmative. The official information from clinicaltrials.gov states that the study is actively recruiting individuals, and was first posted on February 1st 2021 with a most recent update recorded by June 30th 2022. This trial necessitates recruitment of 100 patients to just one site."